Health Care & Life Sciences

Clarian hospital system to adopt IU name

May 5, 2010
J.K. Wall
Clarian will become Indiana University Health early next year in a bet the IU brand carries more punch statewide and nationally.
More

Central Indiana gets $16M in health IT stimulus

May 4, 2010
 IBJ Staff and Bloomberg News
The central Indiana area has been selected as one of 15 communities that will share in $220 million worth of grants for pilot projects to test health-care information technology.
More

Startup sees big potential for 'ouchless' medical testsRestricted Content

May 1, 2010
J.K. Wall
Companion Diagnostics wants to detect early warning signs of chronic diseases.
More

Closing of Purdue's Chao Center is setback for BioCrossroads

May 1, 2010
J.K. Wall
The university is hoping to find a private company to take over the 5-year-old facility, which formulated and manufactured small batches of drugs used in clinical trials.
More

Wishard Foundation appoints new leader

April 30, 2010
Ernest Vargo II's Vargo's top priority will be guiding the foundation's $50 million capital campaign for the construction of the new, $754 million Wishard Hospital.
More

Anthem Blue Cross withdraws big California rate hike

April 29, 2010
Associated Press
Anthem Blue Cross withdrew plans to raise health insurance rates for Californians by as much as 39 percent after an independent audit determined the company's justification for raising premiums was based on flawed data.
More

Medco Health profits climb as it adds big clients

April 28, 2010
 IBJ Staff and Associated Press
Medco, which operates a major pharmacy and distribution center in Whitestown, got a boost from higher prices on brand-name drugs and from greater sales of more profitable generic drugs.
More

Chao exit hurts drug development industry

April 28, 2010
J.K. Wall
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
More

Reform to accelerate health care costs

April 28, 2010
J.K. Wall
Medicare actuary Richard Foster estimated the new law would raise overall health care spending by an additional $311 million over current law—more than when he first examined the legislation in December.
More

WellPoint profits rise, beat analysts' expectations

April 28, 2010
J.K. Wall
The Indianapolis-based health insurer was helped in first quarter by a mild flu season, but it now expects to lose nearly 700,000 customers by year end.
More

WellPoint to adhere to new rescission rules early

April 27, 2010
J.K. Wall
The Indianapolis-based health insurer announced Tuesday afternoon it will be the first company to adopt stricter standards on canceling policies, which are contained in the health reform bill passed in March.
More

Judge rejects Guidant's defibrillator plea deal

April 27, 2010
Bloomberg News
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some doctors and patients complained about the $296 million deal.
More

WellPoint gets lashing from Sebelius, again

April 26, 2010
J.K. Wall
Indianapolis-based health insurer trades jabs with U.S. health secretary after Reuters story claims insurer deliberately cancels coverage for breast cancer patients.
More

Medicare Advantage may survive cuts under health reform

April 26, 2010
 IBJ Staff and Bloomberg News
The two largest U.S. health insurance companies, UnitedHealth, based in Minnetonka, Minn., and WellPoint Inc., based in Indianapolis, sell Advantage plans.
More

Medical device startup FlowCo enlists Guidant alums

April 24, 2010
Chris O'Malley
The upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo Inc. bring its artery-measurement product to market as soon as 2011.
More

Clarian hospital system regains its appetite to buildRestricted Content

April 24, 2010
J.K. Wall
Clarian is planning to spend $1.7 billion in the next five years on capital projects, half of that going to its downtown Indianapolis campuses.
More

New helicopters coming for Indiana medical flights

April 23, 2010
Associated Press
Clarian Health officials on Thursday plan to buy four helicopters as it replaces aircraft in its aging patient-transport fleet.
More

Harlan Labs names new CEO

April 23, 2010
 IBJ Staff
The Indianapolis-based provider of clinical research animals has promoted senior manager Hans Thunem to its top spot.
More

Indy anti-diabetes experiment takes off

April 21, 2010
J.K. Wall
UnitedHealthcare believes a program tested in the Indianapolis area will help it save money on claims.
More

Drug prices rise ahead of rebates

April 21, 2010
J.K. Wall
Drug prices rose faster last year than they have in a decade—just in time for big rebates the drug industry promised as part of the health reform law.
More

Democrats want government approval of health premiums

April 20, 2010
Bloomberg News
Insurers like WellPoint Inc. should be required to get U.S. approval to increase premiums, Sens. Diane Feinstein and Tom Harkin say.
More

Health care tech firm Gemms adding 69 jobs

April 20, 2010
 IBJ Staff
Carmel-based electronic medical records developer Gemms Inc. plans to invest $2.1 million to expand its headquarters and software development operations here, more than doubling its staff in the next five years.
More

Shareholders fail to remove Lilly's anti-takeover provision

April 19, 2010
J.K. Wall
The proposal to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly’s board received approval from shareholders holding 74 percent of Lilly’s shares.
More

Shares fall after Lilly earnings report

April 19, 2010
J.K. Wall
Lilly shareholders are set to gather Monday in Indianapolis to hear an update on the company’s performance, including how it will keep paying its generous dividend during the lean years after Zyprexa’s patent expiration.
More

Lilly to pay $400M to repurchase Cymbalta rights

April 19, 2010
Bloomberg News
Eli Lilly and Co. will repurchase rights to develop and market antidepressant Cymbalta outside the U.S. and Japan from European partner Boehringer Ingelheim for an initial payment of $400 million.
More
Page  << 71 72 73 74 75 76 77 78 79 80 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT